Vita Life Sciences Limited (ASX:VLS)

Market Cap	139.04M +35.0%
Revenue (ttm)	93.27M +17.3%
Net Income	10.44M +18.8%
EPS	0.18 +16.2%
Shares Out	55.39M
PE Ratio	13.68
Forward PE	n/a
Dividend	0.14 (5.38%)
Ex-Dividend Date	Mar 27, 2026

Volume	20,671
Average Volume	23,205
Open	2.560
Previous Close	2.600
Day's Range	2.520 - 2.580
52-Week Range	1.700 - 2.840
Beta	0.50
RSI	46.49
Earnings Date	Feb 24, 2026

About Vita Life Sciences

Vita Life Sciences Limited, a healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China. The company offers various minerals, herbs, and superfoods. It markets its products through pharmacies and health food channels under the Herbs of Gold, VitaHealth, and VitaScience brands. The company was founded in 1947 and is headquartered in Mascot, Australia.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1947
• Employees: 350
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: VLS

Financial Performance

In 2025, Vita Life Sciences's revenue was 93.27 million, an increase of 17.31% compared to the previous year's 79.51 million. Earnings were 10.44 million, an increase of 18.80%.